<P> Between 2007 and 2013, the percentage of cancer patients alive within five years after cancer diagnosis are displayed in the table below . These figures represent all deaths, whether due to the cancer itself, or death from another cause in a person with cancer . </P> <P> Note: This is not a complete list of cancer mortality rates as published by the NCI . These figures are at least five years old and do not reflect recent advances in medicine that have improved the detection and treatments of cancer and their outcomes . Again, these are average death rates that should not be assumed to apply to individuals, whose prognoses will vary depending on age, sex, race, general health, swiftness of detection, type of treatment, progression of disease, and complicating factors . </P> <Table> <Tr> <Th> Type </Th> <Th> Survival Rate </Th> </Tr> <Tr> <Td> Oral Cancer </Td> <Td> 64.5% </Td> </Tr> <Tr> <Td> Lip cancer </Td> <Td> 90% </Td> </Tr> <Tr> <Td> Hypopharynx cancer </Td> <Td> 33% </Td> </Tr> <Tr> <Td> Esophageal cancer </Td> <Td> 19% </Td> </Tr> <Tr> <Td> Stomach cancer </Td> <Td> 30.6% </Td> </Tr> <Tr> <Td> Small intestine cancer </Td> <Td> 67.5% </Td> </Tr> <Tr> <Td> Colorectal cancer </Td> <Td> 64.9% </Td> </Tr> <Tr> <Td> Hepatic and bile duct cancer </Td> <Td> 17.6% </Td> </Tr> <Tr> <Td> Gallbladder cancer </Td> <Td> 18.2% </Td> </Tr> <Tr> <Td> Pancreatic cancer (all types) </Td> <Td> 8.2% </Td> </Tr> <Tr> <Td> Laryngeal cancer </Td> <Td> 60.7% </Td> </Tr> <Tr> <Td> Lung cancer (all types) </Td> <Td> 18.1% </Td> </Tr> <Tr> <Td> Mesothelioma </Td> <Td> 9% </Td> </Tr> <Tr> <Td> Tracheal cancer </Td> <Td> 52.9% </Td> </Tr> <Tr> <Td> Bone cancer (all types) </Td> <Td> 67.7% </Td> </Tr> <Tr> <Td> Soft tissue, not otherwise specified </Td> <Td> 64.4% </Td> </Tr> <Tr> <Td> Skin cancer (excluding basal and squamous) </Td> <Td> 91.7% </Td> </Tr> <Tr> <Td> Breast cancer </Td> <Td> 89.7% </Td> </Tr> <Tr> <Td> Breast cancer in situ </Td> <Td> 100% </Td> </Tr> <Tr> <Td> Uterine cancer </Td> <Td> 29.8% - 82.7% </Td> </Tr> <Tr> <Td> Ovarian cancer </Td> <Td> 46.5% </Td> </Tr> <Tr> <Td> Cervical cancer </Td> <Td> 67.1% </Td> </Tr> <Tr> <Td> Prostate cancer </Td> <Td> 98.6% </Td> </Tr> <Tr> <Td> Testicular cancer </Td> <Td> 95.1% </Td> </Tr> <Tr> <Td> Bladder cancer </Td> <Td> 77.3% </Td> </Tr> <Tr> <Td> Renal cancer </Td> <Td> 74.1% </Td> </Tr> <Tr> <Td> Ocular cancer </Td> <Td> 82.7% </Td> </Tr> <Tr> <Td> Glioblastoma </Td> <Td> 4% </Td> </Tr> <Tr> <Td> Diffuse Intrinsic Pontine Glioma </Td> <Td> 0% </Td> </Tr> <Tr> <Td> Myeloma </Td> <Td> 49.6% </Td> </Tr> <Tr> <Td> Hodgkin's lymphoma </Td> <Td> 86.4% </Td> </Tr> <Tr> <Td> Non-Hodgkin's lymphoma </Td> <Td> 71% </Td> </Tr> <Tr> <Td> Thyroid cancer </Td> <Td> 98.2% </Td> </Tr> <Tr> <Td> Leukemia (Acute lymphocytic) </Td> <Td> 68.2% </Td> </Tr> <Tr> <Td> Leukemia (Acute myelomonocytic) </Td> <Td> 24% </Td> </Tr> <Tr> <Td> Leukemia (Chronic lymphocytic) </Td> <Td> 83.2% </Td> </Tr> <Tr> <Td> Leukemia (Chronic myeloid) </Td> <Td> 66.9% </Td> </Tr> </Table> <Tr> <Th> Type </Th> <Th> Survival Rate </Th> </Tr>

Which type of cancer has the poorest prognosis